Ross Camidge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ross Camidge has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
D L Stockton
Information Services, NHS National Services Scotland Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK
2 shared publications- David Nicholas Bateman
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Sciences, University of Edinburgh, The Queens Medical Research Institute
2 shared publications Duncan Jodrell
University of Edinburgh, Edinburgh Cancer Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU
2 shared publicationsFiona Nussey
University of Edinburgh, Edinburgh Cancer Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU
2 shared publicationsM Bain
Information Services, NHS National Services Scotland Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK
2 shared publications- Rachael Wood
Public Health Scotland, Edinburgh, UK
2 shared publications
Latest Publications
Frankenstein: or, The Modern Prometheus
Try to put all images of crackling Van de Graaff generators and lumbering, moaning, bolt necked monsters from your mind. Nearly 200 years of oversimplification and spoofs have completely overshadowed the original version of this tale, first published in 1818. So let's set the record straight. While still a student of natural philosophy Victor Frankenstein had an epiphany—although its precise nature is never revealed. Through studying death and decay he discovers “the cause of generation and life,” becoming himself “capable of bestowing animation on lifeless matter.” Although now this would probably first be demonstrated on nematodes, then drosophila, Frankenstein goes straight for the big one: creating …
Frankenstein: or, The Modern Prometheus
Try to put all images of crackling Van de Graaff generators and lumbering, moaning, bolt necked monsters from your mind. Nearly 200 years of oversimplification and spoofs have completely overshadowed the original version of this tale, first published in 1818. So let's set the record straight. While still a student of natural philosophy Victor Frankenstein had an epiphany—although its precise nature is never revealed. Through studying death and decay he discovers “the cause of generation and life,” becoming himself “capable of bestowing animation on lifeless matter.” Although now this would probably first be demonstrated on nematodes, then drosophila, Frankenstein goes straight for the big one: creating …
- Open Access
- 15 August 2007
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (2) , 224-229
The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes
- 15 August 2007
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (2) , 224-229
Open AccessThe impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes
- Open Access
- 13 February 2007
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (5) , 752-757
Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK
The risk of suicide in cancer patients has been reported as elevated in several countries. These patients are exposed to many medicines that may confuse or provide a means for harm, potentially also increasing their risk from accidents. Ratios of observed/expected numbers of hospital admission and death events relating to deliberate self-harm (DSH) and accidents were calculated in the 5 years from a cancer diagnosis in Scotland 1981–1995, compared to the matched general population. The relative risk (RR) of suicide was 1.51 (95% confidence interval (CI): 1.29–1.76). The RR of hospital admissions for DSH was not significantly increased, suggesting a strong suicidal intent in DSH acts in cancer patients. Accidental poisonings and all other accidents were both increased (RR death=3.69, 95% CI: 2.10–6.00; and 1.58, 95% CI: 1.48–1.69, respectively) (RR hospital admissions=1.32, 95% CI: 1.19–1.47; and 1.55, 95% CI: 1.53–1.57, respectively). The association of only certain tumour types (e.g. respiratory) with suicide and accidental poisoning, and a broad range of tumour types with an elevated risk of all other accidents, suggests accidental poisoning categories may be a common destination for code shifting of some DSH events. A previous history of DSH or accidents, significantly increased the RR of suicide or fatal accidents, respectively (RR suicide=14.86 (95% CI: 4.69–34.97) vs 1.16 (95% CI: 0.84–1.55)) (RR accidental death=3.37 (95% CI: 2.53–4.41) vs 1.29 (95% CI: 1.12–1.49)). Within 5 years of a cancer diagnosis, Scottish patients are at increased RR of suicide and fatal accidents, and increased RR of hospital admissions for accidents. Some of these accidents, particularly accidental poisonings, may contain hidden deliberate acts. Previous DSH or accidents are potential markers for those most at risk, in whom to target interventional techniques.
- 13 February 2007
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (5) , 752-757
Open AccessHospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK
The risk of suicide in cancer patients has been reported as elevated in several countries. These patients are exposed to many medicines that may confuse or provide a means for harm, potentially also increasing their risk from accidents. Ratios of observed/expected numbers of hospital admission and death events relating to deliberate self-harm (DSH) and accidents were calculated in the 5 years from a cancer diagnosis in Scotland 1981–1995, compared to the matched general population. The relative risk (RR) of suicide was 1.51 (95% confidence interval (CI): 1.29–1.76). The RR of hospital admissions for DSH was not significantly increased, suggesting a strong suicidal intent in DSH acts in cancer patients. Accidental poisonings and all other accidents were both increased (RR death=3.69, 95% CI: 2.10–6.00; and 1.58, 95% CI: 1.48–1.69, respectively) (RR hospital admissions=1.32, 95% CI: 1.19–1.47; and 1.55, 95% CI: 1.53–1.57, respectively). The association of only certain tumour types (e.g. respiratory) with suicide and accidental poisoning, and a broad range of tumour types with an elevated risk of all other accidents, suggests accidental poisoning categories may be a common destination for code shifting of some DSH events. A previous history of DSH or accidents, significantly increased the RR of suicide or fatal accidents, respectively (RR suicide=14.86 (95% CI: 4.69–34.97) vs 1.16 (95% CI: 0.84–1.55)) (RR accidental death=3.37 (95% CI: 2.53–4.41) vs 1.29 (95% CI: 1.12–1.49)). Within 5 years of a cancer diagnosis, Scottish patients are at increased RR of suicide and fatal accidents, and increased RR of hospital admissions for accidents. Some of these accidents, particularly accidental poisonings, may contain hidden deliberate acts. Previous DSH or accidents are potential markers for those most at risk, in whom to target interventional techniques.
- Open Access
- 8 August 2006
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (5) , 649-652
Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data
ICD-9 code 163 (malignant neoplasm of pleura) listed as underlying cause of death detected only 40% of Scottish mesothelioma cases (all body sites) from the cancer registry in 1981–1999. This is lower than both the previously published 55% figure, derived from UK mesothelioma register data 1986–1991, which is based on any mention of mesothelioma on death certificates, cross-referenced to cancer registry data, and the 44% figure derived from Scottish mortality data 1981–1999, which captured any mention of mesothelioma on the death certificate. Detection from cancer registry data increased to 75% under ICD-10 in Scotland, confirming earlier predictions of the benefit of ICD-10's more specific mesothelioma codes. Including the accidental poisoning codes E866.4 (ICD-9) and X49 (ICD-10), covering poisoning by ‘unspecified’ and ‘other’ causes, which appear to have been used as coding surrogates for mesothelioma when asbestos exposure was explicitly mentioned in deaths suggestive of a mesothelioma, and which are recorded as the underlying cause of death in 4–7% of mesotheliomas, may improve the mesothelioma detection rate in future epidemiological studies.
- 8 August 2006
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (5) , 649-652
Open AccessFactors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data
ICD-9 code 163 (malignant neoplasm of pleura) listed as underlying cause of death detected only 40% of Scottish mesothelioma cases (all body sites) from the cancer registry in 1981–1999. This is lower than both the previously published 55% figure, derived from UK mesothelioma register data 1986–1991, which is based on any mention of mesothelioma on death certificates, cross-referenced to cancer registry data, and the 44% figure derived from Scottish mortality data 1981–1999, which captured any mention of mesothelioma on the death certificate. Detection from cancer registry data increased to 75% under ICD-10 in Scotland, confirming earlier predictions of the benefit of ICD-10's more specific mesothelioma codes. Including the accidental poisoning codes E866.4 (ICD-9) and X49 (ICD-10), covering poisoning by ‘unspecified’ and ‘other’ causes, which appear to have been used as coding surrogates for mesothelioma when asbestos exposure was explicitly mentioned in deaths suggestive of a mesothelioma, and which are recorded as the underlying cause of death in 4–7% of mesotheliomas, may improve the mesothelioma detection rate in future epidemiological studies.
Prognosis without treatment as a modifier in health economic assessments
Explicit rationing—decisions not to fund certain treatments—has become a fact of life in many healthcare systems.1–4 Health economic assessments often underpin rationing decisions, although it remains unclear whether society's values are well reflected by the utilitarian approach of maximising the units of health attainable from available resources.5 6 Health economic assessments are used to determine the additional cost per unit of health gain for different treatment options. Cost effectiveness analysis is the most common method of assessment7 8 and, for life shortening conditions, primarily focuses on the additional cost per life year gained. We propose that prognosis without treatment is an important contextual modifier of life years gained in evaluating treatments for life shortening conditions. We present initial data supporting this hypothesis and describe resource allocation strategies that use this information.
Prognosis without treatment as a modifier in health economic assessments
Explicit rationing—decisions not to fund certain treatments—has become a fact of life in many healthcare systems.1–4 Health economic assessments often underpin rationing decisions, although it remains unclear whether society's values are well reflected by the utilitarian approach of maximising the units of health attainable from available resources.5 6 Health economic assessments are used to determine the additional cost per unit of health gain for different treatment options. Cost effectiveness analysis is the most common method of assessment7 8 and, for life shortening conditions, primarily focuses on the additional cost per life year gained. We propose that prognosis without treatment is an important contextual modifier of life years gained in evaluating treatments for life shortening conditions. We present initial data supporting this hypothesis and describe resource allocation strategies that use this information.
- 20 August 2003
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 56 (6) , 613-619
The epidemiology of self‐poisoning in the UK
Self‐poisoning by ingestion or inhalation is common, and it is important to study its various epidemiological manifestations with clear definitions. Data on fatal self‐poisonings are recorded nationally within the UK and are codified according to the International Classification of Diseases (ICD) revision relevant at the time. Most fatal self‐poisonings are codified as suicides, accidental deaths or undetermined deaths (‘open verdicts’). Non‐fatal self‐poisoning data, whether accidental or as a manifestation of deliberate self‐harm, are recorded through hospital discharge information nationally but are not routinely published in the same way as mortality data. The bulk of the UK's published epidemiological information on nonfatal self‐poisoning episodes is largely based on individual hospitals’ admission or discharge records (‘special studies’). After establishing definitions for different self‐poisoning categories we discuss the published data on self‐poisoning as they relate to suicide, accidental self‐poisoning and deliberate self‐harm in the UK.
- 20 August 2003
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 56 (6) , 613-619
The epidemiology of self‐poisoning in the UK
Self‐poisoning by ingestion or inhalation is common, and it is important to study its various epidemiological manifestations with clear definitions. Data on fatal self‐poisonings are recorded nationally within the UK and are codified according to the International Classification of Diseases (ICD) revision relevant at the time. Most fatal self‐poisonings are codified as suicides, accidental deaths or undetermined deaths (‘open verdicts’). Non‐fatal self‐poisoning data, whether accidental or as a manifestation of deliberate self‐harm, are recorded through hospital discharge information nationally but are not routinely published in the same way as mortality data. The bulk of the UK's published epidemiological information on nonfatal self‐poisoning episodes is largely based on individual hospitals’ admission or discharge records (‘special studies’). After establishing definitions for different self‐poisoning categories we discuss the published data on self‐poisoning as they relate to suicide, accidental self‐poisoning and deliberate self‐harm in the UK.
The Cure: A Story of Cancer and Politics from the Annals of the Cold War
![][1] Nikolai Krementsov University of Chicago Press, $26/£16.50, pp 277 ISBN 0 226 45284 0 Rating: ![Graphic][2] At the end of the second world war, when Russia drew an “iron curtain” across Europe, the secret of atomic power was known only on the Western side. While espionage inevitably proved the most successful strategy in the long run, Russia's earlier plan to acquire this information by swapping it for its own top secret cure for cancer sounds like a great idea for a book, maybe even for a Hollywood film. Unfortunately, the high drama of these events … [1]: /embed/graphic-1.gif [2]: /embed/inline-graphic-1.gif
The Cure: A Story of Cancer and Politics from the Annals of the Cold War
![][1] Nikolai Krementsov University of Chicago Press, $26/£16.50, pp 277 ISBN 0 226 45284 0 Rating: ![Graphic][2] At the end of the second world war, when Russia drew an “iron curtain” across Europe, the secret of atomic power was known only on the Western side. While espionage inevitably proved the most successful strategy in the long run, Russia's earlier plan to acquire this information by swapping it for its own top secret cure for cancer sounds like a great idea for a book, maybe even for a Hollywood film. Unfortunately, the high drama of these events … [1]: /embed/graphic-1.gif [2]: /embed/inline-graphic-1.gif
- Open Access
- 1 November 2001
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 94 (11) , 567-572
The Causes of Dysphagia in Carcinoma of the Lung
Dysphagia occurs in only a small percentage of patients with lung cancer, but the frequency of this cancer means that large numbers are affected. Non-quantitative analysis of a large Scottish series of lung cancer cases indicates the following eight broad categories of dysphagia according to underlying mechanisms: mediastinal disease; cervical lymphadenopathy; brainstem lesions; gastrointestinal tract metastases; associated systemic disorders; second primaries; oropharyngeal and oesophageal infections; and radiation-induced oesophageal toxicity.
- 1 November 2001
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 94 (11) , 567-572
Open AccessThe Causes of Dysphagia in Carcinoma of the Lung
Dysphagia occurs in only a small percentage of patients with lung cancer, but the frequency of this cancer means that large numbers are affected. Non-quantitative analysis of a large Scottish series of lung cancer cases indicates the following eight broad categories of dysphagia according to underlying mechanisms: mediastinal disease; cervical lymphadenopathy; brainstem lesions; gastrointestinal tract metastases; associated systemic disorders; second primaries; oropharyngeal and oesophageal infections; and radiation-induced oesophageal toxicity.